Literature DB >> 8209002

Present status and perspectives of boron neutron capture therapy.

D Gabel1.   

Abstract

Boron neutron capture therapy (BNCT) is a mode of radiotherapy with great attractiveness, but also with a burden of past failure. In this review, the principles of BNCT, the reasons for its past failure, its present clinical application, and the on-going developmental work towards clinical trials are described.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8209002     DOI： 10.1016/0167-8140(94)90458-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  6 in total

Review 1.  Targeted drug delivery for boron neutron capture therapy.

Authors:  S C Mehta; D R Lu
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

2.  Binding and distribution of Na2B12H11SH on cellular and subcellular level in tumor tissue of glioma patients in boron neutron capture therapy.

Authors:  B Otersen; D Haritz; F Grochulla; M Bergmann; W Sierralta; D Gabel
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

3.  Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors.

Authors:  T Kageji; Y Nakagawa; K Kitamura; K Matsumoto; H Hatanaka
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

4.  Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.

Authors:  Teruyoshi Kageji; Shinji Nagahiro; Birte Otersen; Detlef Gabel; Manekazu Nakaichi; Yoshinobu Nakagawa
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

Review 5.  Ligand liposomes and boron neutron capture therapy.

Authors:  Jörgen Carlsson; Erika Bohl Kullberg; Jacek Capala; Stefan Sjöberg; Katarina Edwards; Lars Gedda
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

Review 6.  Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with 10B-Borocaptate Sodium (BSH) and 10B-Paraboronophenylalanine (BPA).

Authors:  Hiroshi Fukuda
Journal:  Cells       Date:  2021-10-26       Impact factor: 6.600
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.